Iona Walton
Golimumab well tolerated in rheumatoid arthritis says data review
Golimumab, a biologic drug for people with rheumatoid arthritis, appears to be effective and well tolerated, according to a review of the evidence in the Journal of Clinical Medicine. Continue reading
Gene therapy: the future of rheumatoid arthritis treatment?
Advances in gene therapy will open new safe and effective treatment options for people with rheumatoid arthritis in the future, scientists outline in the Journal of Cellular Physiology. Continue reading
Baricitinib NOT linked to adverse cardiovascular outcomes in rheumatoid arthritis in latest review
Trials have found that there does not seem to be an association between baricitinib treatment and major adverse cardiovascular events, arterial thrombotic events or congestive heart failure in people with rheumatoid arthritis. Continue reading
Tramadol may be linked to higher death rates in older people with osteoarthritis
An initial prescription of tramadol for osteoarthritis in people aged 50 years and older is associated with increased risk of death within a year compared to some other pain relief options, says a large new study in JAMA. More research is needed to find out if the association is causal. Continue reading
Knee pain is not linked to daily walking levels in people with osteoarthritis
People with knee osteoarthritis are often afraid of their pain and start walking less as a consequence, but this could be set to change. Continue reading
